Currently holds positions in Tocagen Inc, Amylin Pharmaceuticals LLC, AMN Healthcare Services Inc and DexCom Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Executive Vice President | Tocagen Inc | Feb. 1, 2017 - |
Chief Financial Officer, Senior Vice President - Finance | Amylin Pharmaceuticals LLC | March 1, 2006 - |
Independent Director | AMN Healthcare Services Inc | Dec. 12, 2012 - |
Lead Independent Director | DexCom Inc | Nov. 1, 2015 - |
Independent Director | Regulus Therapeutics Inc | Jan. 31, 2013 - April 1, 2018 |
Interim Chief Financial Officer | Biocept Inc | Aug. 21, 2015 - July 27, 2016 |
Independent Director | DexCom Inc | Nov. 19, 2014 - Nov. 1, 2015 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-01 | 2024-02-29 | B Purchase |
500
+6.2%
56.9028,450 USD |
500 +6.2% | 56.90 | 28,450 USD | ||
2023-04-25 | 2023-04-21 | PS Planned sale |
1,458
-15.3%
88.78129,441 USD |
1,458 -15.3% | 88.78 | 129,441 USD | ||
2023-04-13 | 2023-04-11 | PS Planned sale |
1,053
-11.5%
84.6389,115 USD |
1,053 -11.5% | 84.63 | 89,115 USD | ||
2023-04-13 | 2023-04-11 | PS Planned sale |
4,989
-35.3%
84.29420,523 USD |
4,989 -35.3% | 84.29 | 420,523 USD | ||
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
41
-0.3%
569.5423,351 USD |
41 -0.3% | 569.54 | 23,351 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
2
-0.0%
567.351,135 USD |
2 -0.0% | 567.35 | 1,135 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
87
-0.7%
565.5149,200 USD |
87 -0.7% | 565.51 | 49,200 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
65
-0.5%
564.2436,675 USD |
65 -0.5% | 564.24 | 36,675 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
116
-0.9%
562.7965,283 USD |
116 -0.9% | 562.79 | 65,283 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
78
-0.6%
561.8543,824 USD |
78 -0.6% | 561.85 | 43,824 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
70
-0.5%
558.7839,115 USD |
70 -0.5% | 558.78 | 39,115 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
41
-0.3%
556.8922,832 USD |
41 -0.3% | 556.89 | 22,832 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
40
-0.3%
634.0125,360 USD |
40 -0.3% | 634.01 | 25,360 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
40
-0.3%
631.2625,250 USD |
40 -0.3% | 631.26 | 25,250 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
42
-0.3%
629.3326,432 USD |
42 -0.3% | 629.33 | 26,432 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
76
-0.6%
628.4147,759 USD |
76 -0.6% | 628.41 | 47,759 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
56
-0.4%
627.7935,156 USD |
56 -0.4% | 627.79 | 35,156 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
7
-0.1%
626.054,382 USD |
7 -0.1% | 626.05 | 4,382 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
124
-0.9%
625.3277,540 USD |
124 -0.9% | 625.32 | 77,540 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
43
-0.3%
624.1026,836 USD |
43 -0.3% | 624.10 | 26,836 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
13
-0.1%
622.638,094 USD |
13 -0.1% | 622.63 | 8,094 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
14
-0.1%
619.328,670 USD |
14 -0.1% | 619.32 | 8,670 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
45
-0.3%
615.1327,681 USD |
45 -0.3% | 615.13 | 27,681 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
1
-0.0%
551.58552 USD |
1 -0.0% | 551.58 | 552 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
51
-0.4%
547.0627,900 USD |
51 -0.4% | 547.06 | 27,900 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
181
-1.3%
544.3998,535 USD |
181 -1.3% | 544.39 | 98,535 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
126
-0.9%
543.1568,437 USD |
126 -0.9% | 543.15 | 68,437 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
88
-0.6%
540.9347,602 USD |
88 -0.6% | 540.93 | 47,602 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
6
-0.0%
539.103,235 USD |
6 -0.0% | 539.10 | 3,235 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
PS Planned sale |
47
-0.3%
538.0225,287 USD |
47 -0.3% | 538.02 | 25,287 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
PS Planned sale |
301
-2.2%
342.93103,222 USD |
301 -2.2% | 342.93 | 103,222 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
PS Planned sale |
428
-3.1%
341.79146,284 USD |
428 -3.1% | 341.79 | 146,284 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
PS Planned sale |
117
-0.8%
340.2339,807 USD |
117 -0.8% | 340.23 | 39,807 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
PS Planned sale |
139
-1.0%
337.7846,951 USD |
139 -1.0% | 337.78 | 46,951 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
PS Planned sale |
15
-0.1%
336.985,055 USD |
15 -0.1% | 336.98 | 5,055 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
208
-1.4%
398.2582,835 USD |
208 -1.4% | 398.25 | 82,835 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
375
-2.5%
397.41149,030 USD |
375 -2.5% | 397.41 | 149,030 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
255
-1.7%
396.51101,109 USD |
255 -1.7% | 396.51 | 101,109 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
120
-0.8%
395.0247,402 USD |
120 -0.8% | 395.02 | 47,402 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
42
-0.3%
391.4816,442 USD |
42 -0.3% | 391.48 | 16,442 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
PS Planned sale |
114
-0.7%
397.7545,344 USD |
114 -0.7% | 397.75 | 45,344 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
PS Planned sale |
121
-0.8%
396.1747,936 USD |
121 -0.8% | 396.17 | 47,936 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
PS Planned sale |
222
-1.4%
395.2887,753 USD |
222 -1.4% | 395.28 | 87,753 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
PS Planned sale |
231
-1.5%
393.7390,951 USD |
231 -1.5% | 393.73 | 90,951 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
PS Planned sale |
200
-1.2%
391.9578,390 USD |
200 -1.2% | 391.95 | 78,390 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
PS Planned sale |
109
-0.7%
390.8642,604 USD |
109 -0.7% | 390.86 | 42,604 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
PS Planned sale |
3
-0.0%
386.211,159 USD |
3 -0.0% | 386.21 | 1,159 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
84
-0.6%
288.2624,214 USD |
84 -0.6% | 288.26 | 24,214 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
75
-0.6%
285.4821,411 USD |
75 -0.6% | 285.48 | 21,411 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
84
-0.6%
282.7723,753 USD |
84 -0.6% | 282.77 | 23,753 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
53
-0.4%
281.6114,925 USD |
53 -0.4% | 281.61 | 14,925 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
31
-0.2%
279.608,668 USD |
31 -0.2% | 279.60 | 8,668 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
64
-0.5%
277.4817,759 USD |
64 -0.5% | 277.48 | 17,759 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
114
-0.8%
275.5631,414 USD |
114 -0.8% | 275.56 | 31,414 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
155
-1.1%
274.8842,607 USD |
155 -1.1% | 274.88 | 42,607 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
81
-0.6%
272.8222,098 USD |
81 -0.6% | 272.82 | 22,098 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
152
-1.1%
271.5441,274 USD |
152 -1.1% | 271.54 | 41,274 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
107
-0.8%
270.6328,957 USD |
107 -0.8% | 270.63 | 28,957 USD | |
2020-02-05 | 2020-02-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
9
-0.1%
240.682,166 USD |
9 -0.1% | 240.68 | 2,166 USD | |
2020-02-05 | 2020-02-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
166
-1.2%
238.8639,650 USD |
166 -1.2% | 238.86 | 39,650 USD | |
2020-02-05 | 2020-02-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
524
-3.5%
238.05124,736 USD |
524 -3.5% | 238.05 | 124,736 USD | |
2020-02-05 | 2020-02-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
301
-2.0%
236.8471,290 USD |
301 -2.0% | 236.84 | 71,290 USD | |
2020-01-07 | 2020-01-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
133
-0.9%
218.9429,118 USD |
133 -0.9% | 218.94 | 29,118 USD | |
2020-01-07 | 2020-01-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
339
-2.2%
218.3974,035 USD |
339 -2.2% | 218.39 | 74,035 USD | |
2020-01-07 | 2020-01-03 |
DexCom Inc
(DXCM)
|
PS Planned sale |
528
-3.3%
217.61114,899 USD |
528 -3.3% | 217.61 | 114,899 USD | |
2019-05-29 | 2019-05-28 |
Tocagen Inc
(TOCA)
|
PP Planned purchase |
5,000
+49.8%
4.3021,475 USD |
5,000 +49.8% | 4.30 | 21,475 USD | |
2019-05-17 | 2019-05-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
400
-3.0%
122.7349,091 USD |
400 -3.0% | 122.73 | 49,091 USD | |
2019-05-17 | 2019-05-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
500
-3.6%
121.8860,939 USD |
500 -3.6% | 121.88 | 60,939 USD | |
2019-05-17 | 2019-05-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
100
-0.7%
118.6511,865 USD |
100 -0.7% | 118.65 | 11,865 USD | |
2019-04-17 | 2019-04-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
599
-4.1%
119.3671,497 USD |
599 -4.1% | 119.36 | 71,497 USD | |
2019-04-17 | 2019-04-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
301
-2.0%
118.8835,784 USD |
301 -2.0% | 118.88 | 35,784 USD | |
2019-04-17 | 2019-04-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
100
-0.7%
116.9611,696 USD |
100 -0.7% | 116.96 | 11,696 USD | |
2019-03-19 | 2019-03-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
100
-0.7%
151.9715,197 USD |
100 -0.7% | 151.97 | 15,197 USD | |
2019-03-19 | 2019-03-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
700
-4.4%
151.00105,698 USD |
700 -4.4% | 151.00 | 105,698 USD | |
2019-03-19 | 2019-03-15 |
DexCom Inc
(DXCM)
|
PS Planned sale |
200
-1.2%
146.9229,384 USD |
200 -1.2% | 146.92 | 29,384 USD |